pf-06463922 and Nephrotic-Syndrome

pf-06463922 has been researched along with Nephrotic-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for pf-06463922 and Nephrotic-Syndrome

ArticleYear
The risk of nephrotic syndrome with non-VEGF inhibitory antineoplastic drugs: from viewpoint of the adverse event reports in Japan.
    Clinical and experimental nephrology, 2021, Volume: 25, Issue:1

    Topics: Adverse Drug Reaction Reporting Systems; Aminopyridines; Antineoplastic Agents; Dasatinib; Humans; Japan; Lactams; Nephrotic Syndrome; Odds Ratio; Pyrazoles; Risk Factors; Vascular Endothelial Growth Factor A

2021